China's Best One-Stop Medical Equipment Provider
About

SSI Diagnostica Group is a global leader in developing, manufacturing, and distributing in vitro diagnostic (IVD) products, focusing on infectious and tropical diseases. Headquartered in Hillerød, Denmark, the company operates facilities in Denmark, the United States, and China, employing over 600 people worldwide. It was originally part of the Danish National Reference Center and is now privately held by Adelis Equity. The company specializes in producing high-quality antisera for vaccine development and rapid diagnostic tests for disease surveillance and diagnosis. Its product portfolio addresses gastrointestinal, respiratory, and bloodborne diseases, including tropical diseases like dengue. SSI Diagnostica comprises four companies: SSI Diagnostica A/S, TECHLAB®, CTK Biotech, and Beijing Genesee Biotech, Inc., each contributing to its extensive range of diagnostic solutions. The company has seen significant growth since its establishment in 2016, particularly in response to the COVID-19 pandemic, where it developed high-quality rapid tests at scale.

Technologies
Cloudflare DNSOutlookWP EngineMagentoAI
Keywords
microbiologydiagnosticsivdmedical equipment manufacturingrapid antigen testspcr testingbacterial strainsvaccine quality controlanimal blood productsvaccine developmentculture mediaantisera productionantigensdiagnostic kitsdisease monitoringantiseravaccinesparasitology diagnosticstropical disease testingsample transport mediagovernmentb2biso 13485 certifiedserologydisease surveillanceinfectious disease diagnosticssexually transmitted infections diagnosticsoutbreak investigation toolspcrdiagnostic research
Company Information
  • Employees130
  • Founded2016
  • Annual Revenue$850000000
Location

2 Herredsvejen, Hillerod, Capital Region of Denmark, Denmark, 3400

Related Companies
Companies in the same industry